AstraZeneca antibody cocktail works against Omicron in study
AstraZeneca said on Thursday a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron coronavirus variant, showing promise for wider use of Continue Reading
